Group One Trading, L.P. Ascendis Pharma A/S Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $255,200 - $377,495	2,964 Added 104.22%	5,808 $731,000
Q3 2023 Nov 09, 2023	BUY	$86.5 - $103.97 $246,006 - $295,690	2,844 New	2,844 $266,000
Q4 2022 Feb 09, 2023	SELL	$99.42 - $131.97 $1.6 Million - $2.13 Million	-16,130 Reduced 92.89%	1,235 $150,000
Q3 2022 Nov 09, 2022	BUY	$84.03 - $110.23 $951,303 - $1.25 Million	11,321 Added 187.31%	17,365 $1.79 Million
Q2 2022 Aug 11, 2022	BUY	$78.08 - $117.61 $471,915 - $710,834	6,044 New	6,044 $562,000
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $1,239 - $1,946	-11 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$121.62 - $145.29 $26,756 - $31,963	-220 Reduced 95.24%	11 $1,000
Q1 2021 May 12, 2021	SELL	$124.92 - $173.33 $88,693 - $123,064	-710 Reduced 75.45%	231 $30,000
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $142,279 - $171,977	941 New	941 $157,000
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $63,085 - $88,769	-569 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$97.01 - $145.11 $118,255 - $176,889	-1,219 Reduced 68.18%	569 $64,000
Q4 2019 Feb 10, 2020	BUY	$91.45 - $139.12 $51,669 - $78,602	565 Added 46.2%	1,788 $249,000
Q3 2019 Nov 12, 2019	SELL	$95.8 - $118.9 $420,753 - $522,208	-4,392 Reduced 78.22%	1,223 $118,000
Q2 2019 Aug 09, 2019	BUY	$107.11 - $132.09 $601,422 - $741,685	5,615 New	5,615 $647,000
Q1 2019 May 13, 2019	SELL	$62.15 - $129.99 $83,591 - $174,836	-1,345 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$55.16 - $69.67 $74,190 - $93,706	1,345 New	1,345 $84,000
Q3 2018 Nov 08, 2018	SELL	$63.77 - $76.28 $6,249 - $7,475	-98 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$58.55 - $73.92 $5,737 - $7,244	98 New	98 $7,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

Ra Capital Management, L.P. Boston, MA

9.71M
Shares

$1.32 Billion
20.22% of portfolio
Westfield Capital Management CO LP Boston, MA

5.13M
Shares

$700 Million
3.62% of portfolio
Avoro Capital Advisors LLC New York, NY

4.99M
Shares

$680 Million
11.21% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

4.41M
Shares

$602 Million
1.03% of portfolio
Janus Henderson Group PLC London, X0

4.19M
Shares

$571 Million
0.33% of portfolio

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account